Skip to main content

Table 1 Characteristics of the subjects at the baseline by groups of walking speed

From: Improving walking speed reduces hospitalization costs in outpatients with cardiovascular disease. An analysis based on a multistrata non-parametric test

 

All subjects

SLOW walkers

FAST walkers

 

(n = 649

(n = 332)

(n = 317)

Walking speed (km/h)

4,2 (1,0)

3,4 (0,7)

5,0 (0,6)

General

 Age (yr)

63 (9)

66 (9)

60 (9)

 Gender (M/F)

568/81

263/69

305/12

 BMI (kg/m2)

27,9 (3,8)

28,4 (4,0)

27,4 (3,5)

 LV ejection fraction (%)

56 (10)

55 (10)

58 (9)

Risk factor

 Current smoking (%)

5

3

6

 Hypertension (%)

60

70

55

 Famili history (%)

53

44

62

 Fasting glucose (mg/dL)

106 (25)

108 (26)

104 (23)

 Total cholesterol (mg/dL)

194 (41)

196 (41)

191 (42)

 HDL cholesterol (mg/dL)

50 (12)

50 (12)

50 (12)

 Serum truglycerides (mg (dL)

135 (67)

137 (37)

132 (68)

 Serum creatinine (mg/dL)

1,09 (0,3)

1,13 (0,3)

1,05 (0,2)

Medical history

 CABG (%)

56

60

52

 Myocardial infarction (%)

21

18

27

 PTCA (%)

8

6

9

 Valvular repair/replacement (%)

11

13

8

 Other (%)

4

3

4

Medications

 ACE inhibitor or ARB (%)

55

60

50

 Aspirin (%)

75

73

77

 β-blockers (%)

59

56

62

 Calcium antagonists (%)

13

14

12

 Diuretics (%)

15

24

5

 Statins (%)

55

49

61

  1. Values are presented as mean (standard deviation, SD) or %. Abbreviations: ACE Angiotensin-Converting Enzyme, ARB Angiotensin Receptor Blocker, BMI Body Mass Index, CABG Coronary Artery Bypass Graft, HDL High-density lipoproteins, LV Left Ventricular, PTCA Percutaneous Transluminal Coronary Angioplasty, stenting or both